Neurológia pre prax 6/2011
The use of monoclonal antibodies in neurology
Monoclonal antibodies currently represent one of the highest stages of pharmacological development. In contrast to previous opinions, it seems that they will be applied not only to treat autoimmune diseases, but their real clinical use will obviously be broader including, for example, tumour-related problems. The review article provides current information on the real and potential use of monoclonal antibodies in neurological diseases.
Keywords: monoclonal antibodies, treatment of neurological diseases, multiple sclerosis.
